0000899243-18-017603.txt : 20180621 0000899243-18-017603.hdr.sgml : 20180621 20180621164239 ACCESSION NUMBER: 0000899243-18-017603 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180619 FILED AS OF DATE: 20180621 DATE AS OF CHANGE: 20180621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAMATTINA JOHN L CENTRAL INDEX KEY: 0001216074 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 18912208 MAIL ADDRESS: STREET 1: 81 WYMAN ST STREET 2: POST OFFICE BOX 9046 CITY: WALTHAM STATE: MA ZIP: 02454 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-19 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001216074 LAMATTINA JOHN L 3911 SORRENTO VALLEY BOULEVARD, SUITE 110 SAN DIEGO CA 92121 1 0 0 0 Common Stock 2018-06-19 4 A 0 493 0.00 A 21449 D Non-Qualified Stock Option (right to buy) 76.77 2018-06-19 4 A 0 2474 0.00 A 2028-06-18 Common Stock 2474 2474 D Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant. /s/ Charles S. Berkman, Attorney-in-Fact 2018-06-21